These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1847120)

  • 61. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine].
    Maisonneuve P; Noël L
    Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098
    [No Abstract]   [Full Text] [Related]  

  • 62. Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.
    Baskin G; DiNello R; Polito A; Quan S; Lee WS; Wu J; Nelles M; Lee S
    Gut; 1993; 34(2 Suppl):S61. PubMed ID: 7686119
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Goffin E; Pirson Y; Cornu C; Jadoul M; van Ypersele de Strihou C
    Lancet; 1994 Apr; 343(8901):854. PubMed ID: 7511196
    [No Abstract]   [Full Text] [Related]  

  • 64. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis C antibody assay in a longitudinal study of haemophiliacs.
    Lim SG; Lee CA; Charman H; Tilsed G; Griffiths PD; Kernoff PB
    Br J Haematol; 1991 Jul; 78(3):398-402. PubMed ID: 1651756
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative results in detection of HCV antibodies by using a rapid HCV test, ELISA and immunoblot.
    Poovorawan Y; Theamboonlers A; Chumdermpadetsuk S; Thong CP
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):647-9. PubMed ID: 7545315
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatitis C virus markers and de novo liver disease after transplantation: a prospective study.
    Franco A; Muñoz C; Jimenez L; Verdejo F; Arenas D; Olivares J
    Transplant Proc; 1995 Aug; 27(4):2260-1. PubMed ID: 7544499
    [No Abstract]   [Full Text] [Related]  

  • 68. [Significance of ALT increase in blood donors with antiviral antibodies of hepatitis C with negative first generation ELISA].
    Suárez A; Navascues CA; Rodríguez M; Rodrigo L
    Med Clin (Barc); 1992 Jun; 99(5):198-9. PubMed ID: 1324384
    [No Abstract]   [Full Text] [Related]  

  • 69. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors.
    Darwish MA; Raouf TA; Rushdy P; Constantine NT; Rao MR; Edelman R
    Am J Trop Med Hyg; 1993 Oct; 49(4):440-7. PubMed ID: 7692754
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [ELISA kits for detection of anti-HCV antibodies. "Viral Hepatitis" Working Group of the French Society of Blood Transfusion].
    Janot C
    Transfus Clin Biol; 1994; 1(1):47-8. PubMed ID: 7514475
    [No Abstract]   [Full Text] [Related]  

  • 71. Hepatitis C antibodies among blood donors in Qatar.
    Lema AM; Cox EA
    Vox Sang; 1992; 63(3):237. PubMed ID: 1333139
    [No Abstract]   [Full Text] [Related]  

  • 72. Variable results of first-generation anti-HCV enzyme immunoassay during follow-up of blood donors.
    Caspari G; Gerlich WH; Beyer J; Schmitt H
    Vox Sang; 1993; 64(1):61-2. PubMed ID: 8383378
    [No Abstract]   [Full Text] [Related]  

  • 73. Sporadic vs. posttransfusion hepatitis C: why the differences?
    Achord JL
    Gastroenterology; 1991 Oct; 101(4):1133-4. PubMed ID: 1716237
    [No Abstract]   [Full Text] [Related]  

  • 74. Hepatitis C: evaluating the seropositive blood donor.
    Martin P; Friedman L
    Hepatology; 1992 May; 15(5):967-9. PubMed ID: 1568738
    [No Abstract]   [Full Text] [Related]  

  • 75. Development of screening and confirmation tests for antibodies to hepatitis C virus.
    Couroucé AM; Janot C
    Curr Stud Hematol Blood Transfus; 1994; (61):36-48. PubMed ID: 7525156
    [No Abstract]   [Full Text] [Related]  

  • 76. Testing of blood for antibodies to hepatitis C virus--implications for plasma pools used in the preparation of blood products.
    Minor P
    Biologicals; 1991 Jul; 19(3):253-6. PubMed ID: 1659432
    [No Abstract]   [Full Text] [Related]  

  • 77. Hepatitis C: new guidelines for donor testing.
    Townsend TR
    Am J Infect Control; 1991 Oct; 19(5):221-4. PubMed ID: 1661564
    [No Abstract]   [Full Text] [Related]  

  • 78. Limitations of serological assays for hepatitis C virus screening in blood donors.
    Fernández E; Riestra S; Suárez A; San Román F; Rodríguez M; Rodrigo L
    J Hepatol; 1993 Aug; 19(1):183-4. PubMed ID: 7507952
    [No Abstract]   [Full Text] [Related]  

  • 79. Prevalence of anti-HCV antibodies in patients with acute nonA-nonB viral hepatitis.
    Giuberti T; Marchelli S; Degli Antoni A; Magnani G; Cavalli A; Pizzaferri P; Schianchi C; Ferrari C; Fiaccadori F
    Arch Virol Suppl; 1992; 4():321-2. PubMed ID: 1333328
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Significance of "borderline" reactivity in tests for antibody to hepatitis C virus in blood donors.
    Belloni M; Alghisi A; Ferrazzi F; Diamantini A; Chemello L; Alberti A
    Transfusion; 1991 Oct; 31(8):781-2. PubMed ID: 1656556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.